Generation of induced pluripotent stem cells, KCi001-A derived from a Bardet-Biedl syndrome patient compound heterozygous for the BBS1 variants c.1169T>G/c.1135G>C

Stem Cell Res. 2018 Aug:31:235-239. doi: 10.1016/j.scr.2018.08.005. Epub 2018 Aug 10.

Abstract

Bardet-Biedl syndrome (BBS) is an autosomal recessive ciliopathy with a wide range of symptoms including obesity, retinal dystrophy, polycystic kidney disease, polydactyly, hypogonadism and learning difficulties. Here we describe the successful generation of an induced pluripotent stem cell (iPSC) KCi001-A from a BBS patient compound heterozygous for two disease causing BBS1 variants c.1169T>G, p. (Met390Arg)/c.1135G>C, p.(Gly370Arg). Resource table.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bardet-Biedl Syndrome / genetics*
  • Female
  • Genotype
  • Humans
  • Induced Pluripotent Stem Cells / metabolism*
  • Microtubule-Associated Proteins / genetics*
  • Mutation

Substances

  • Bbs1 protein, human
  • Microtubule-Associated Proteins